Manifestation of acute appendicitis as known but paradox visceral side effect of ulcerative colitis anti-inflammatory therapy with januskinase-inhibitor Tofacitinib (Xeljanz)-论文-万方医学网

Manifestation of acute appendicitis as known but paradox visceral side effect of ulcerative colitis anti-inflammatory therapy with januskinase-inhibitor Tofacitinib (Xeljanz)

导出原文传递

翻译打印收藏纠错

作者： Weber, F. ^[1] ; Eger, K., I ^[2] ; March, C. ^[3] ; Croner, R. S. ^[4] ; Meyer, F.

作者单位： Dept. of General, Abdominal, Vascular and Transplant Surgery, Germany. ^[1] Inst Pathol ^[2] Inst PatholOtto Von Guericke Univ Univ Hosp Dept Radiol & Nucl Med ^[3] Inst PatholOtto Von Guericke Univ Univ Hosp Dept Radiol & Nucl Med Otto von Guericke Univ Otto von ^[4]

关键词 Scientific case report Ulcerative colitis Acute appendicitis Anti-inflammatory Medication JAK inhibitor Immunomodulation INDUCTION

发布时间 2024-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Manifestation of acute appendicitis as known but paradox visceral side effect of ulcerative colitis anti-inflammatory therapy with januskinase-inhibitor Tofacitinib (Xeljanz)

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Manifestation of acute appendicitis as known but paradox visceral side effect of ulcerative colitis anti-inflammatory therapy with januskinase-inhibitor Tofacitinib (Xeljanz)

相似文献

相关期刊

检索历史清除